Daily FNArena News

A new trend in global finance is putting executive remuneration in the spotlight. Boards and shareholders are not necessarily always singing from the same song sheet.

Pitt Street Research updates on Sensera, following the company’s trading update release.

CYBG is underperforming a weak UK banking sector, as redemptions and margin pressures take their toll. Then there is Brexit.

Orica believes its technological breakthrough should offer a competitive advantage and contribute to earnings growth in FY21. Yet brokers assess the positive outlook is already factored into the shares.

Credit Corp delivered its traditionally conservative guidance at its FY19 results and brokers assess where the upside may lie.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. CIMIC Group has been hampered by soft activity in Hong Kong and timing of Australian projects.

Michael Gable of Fairmont Equities suggests Nanosonics should continue higher from here.

After a strong FY19, sleep apnoea specialist ResMed is expected to make further inroads into market share in FY20 with its “connected-care” strategy.

Weaker economic conditions and increased competition look like hampering automotive and water product distributor GUD Holdings in the year ahead.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.